HRP20120257T1 - Antagonisti receptora 5-ht7 - Google Patents

Antagonisti receptora 5-ht7 Download PDF

Info

Publication number
HRP20120257T1
HRP20120257T1 HR20120257T HRP20120257T HRP20120257T1 HR P20120257 T1 HRP20120257 T1 HR P20120257T1 HR 20120257 T HR20120257 T HR 20120257T HR P20120257 T HRP20120257 T HR P20120257T HR P20120257 T1 HRP20120257 T1 HR P20120257T1
Authority
HR
Croatia
Prior art keywords
hydrogen
methyl
compound according
compound
fluorine
Prior art date
Application number
HR20120257T
Other languages
English (en)
Croatian (hr)
Inventor
O. Badescu Valentina
Ann Filla Sandra
Thaddeus Gallagher Peter
Ann Whatton Maria
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HRP20120257T1 publication Critical patent/HRP20120257T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20120257T 2007-10-12 2008-09-30 Antagonisti receptora 5-ht7 HRP20120257T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97946407P 2007-10-12 2007-10-12
PCT/US2008/078294 WO2009048765A1 (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists

Publications (1)

Publication Number Publication Date
HRP20120257T1 true HRP20120257T1 (hr) 2012-04-30

Family

ID=40134870

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120257T HRP20120257T1 (hr) 2007-10-12 2008-09-30 Antagonisti receptora 5-ht7

Country Status (19)

Country Link
US (1) US7910588B2 (OSRAM)
EP (1) EP2201002B1 (OSRAM)
JP (1) JP5291716B2 (OSRAM)
KR (1) KR101161070B1 (OSRAM)
CN (1) CN101821257B (OSRAM)
AT (1) ATE548365T1 (OSRAM)
AU (1) AU2008311154B2 (OSRAM)
BR (1) BRPI0818450A2 (OSRAM)
CA (1) CA2699674C (OSRAM)
CY (1) CY1112709T1 (OSRAM)
DK (1) DK2201002T3 (OSRAM)
EA (1) EA016787B1 (OSRAM)
ES (1) ES2380756T3 (OSRAM)
HR (1) HRP20120257T1 (OSRAM)
MX (1) MX2010003986A (OSRAM)
PL (1) PL2201002T3 (OSRAM)
PT (1) PT2201002E (OSRAM)
SI (1) SI2201002T1 (OSRAM)
WO (1) WO2009048765A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI396857B (zh) * 2009-12-30 2013-05-21 Etron Technology Inc 晶片測試電路
EP2766353B1 (en) 2011-10-11 2015-06-17 UCB Pharma, S.A. 2-oxo-piperidinyl derivatives
ES2804545T3 (es) 2013-03-11 2021-02-08 Univ Temple Nuevos moduladores de la actividad del receptor de 5-hidroxitriptamina 7 y su método de uso
TW201601632A (zh) * 2013-11-20 2016-01-16 杜邦股份有限公司 1-芳基-3-烷基吡唑殺蟲劑
US10544117B2 (en) 2014-09-10 2020-01-28 Temple University—Of the Commonwealth System of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
IL309982A (en) 2016-11-15 2024-03-01 Univ Temple New modulators of 5-hydroxytryptamine receptor 7 and a method of using them
US11220505B2 (en) 2017-03-21 2022-01-11 Temple University-Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) * 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US20030008880A1 (en) 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
MXPA05008137A (es) * 2003-01-31 2005-09-30 Pfizer Prod Inc Antagonistas y agonistas de 5ht7.
US7211783B2 (en) 2004-01-09 2007-05-01 Tamperproof Container Licensing Corp. Tamper-proof container
JP2008501031A (ja) 2004-05-28 2008-01-17 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体のモジュレーター
TW200914020A (en) * 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Also Published As

Publication number Publication date
AU2008311154A1 (en) 2009-04-16
CA2699674C (en) 2013-07-16
CA2699674A1 (en) 2009-04-16
US7910588B2 (en) 2011-03-22
AU2008311154B2 (en) 2013-09-26
CN101821257B (zh) 2013-05-22
ES2380756T3 (es) 2012-05-18
JP2011500575A (ja) 2011-01-06
EP2201002B1 (en) 2012-03-07
EA016787B1 (ru) 2012-07-30
CY1112709T1 (el) 2016-02-10
JP5291716B2 (ja) 2013-09-18
SI2201002T1 (sl) 2012-04-30
DK2201002T3 (da) 2012-04-10
PT2201002E (pt) 2012-04-27
KR101161070B1 (ko) 2012-07-13
BRPI0818450A2 (pt) 2015-05-12
CN101821257A (zh) 2010-09-01
PL2201002T3 (pl) 2012-07-31
WO2009048765A1 (en) 2009-04-16
EA201070462A1 (ru) 2010-10-29
EP2201002A1 (en) 2010-06-30
MX2010003986A (es) 2010-04-27
ATE548365T1 (de) 2012-03-15
US20100197700A1 (en) 2010-08-05
KR20100054853A (ko) 2010-05-25

Similar Documents

Publication Publication Date Title
HRP20120257T1 (hr) Antagonisti receptora 5-ht7
EP4467549A3 (en) Intermediates of n-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide derivatives
RU2009128966A (ru) Новые производные аминопиримидина в качестве ингибиторов plr1
HRP20180528T1 (hr) Derivati naftiridina, korisni kao antagonisti alfa-v-beta-6 integrina
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
SE0202463D0 (sv) Novel compounds
HRP20210459T1 (hr) Supstituirani derivati oksopiridina
NO20075059L (no) Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
NZ564696A (en) Glucocorticoid, indazole, mimetics, methods of making them, pharmaceutical compositions, and uses thereof
MX2009011964A (es) Derivados heterociclicos pirrolo-nitrogenosos, su preparacion y uso farmaceutico.
NO20060774L (no) Kinolin- og kinazolinderivater som har affinitet for 5HT1-typereseptorer
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
PH12021550687A1 (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
CY1114803T1 (el) Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης
NO20080670L (no) Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
SE0402762D0 (sv) Indazole sulphonamide derivatives
TW200508207A (en) New benzimidazole derivatives
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
NO20064705L (no) Nye farmasoytiske preparater omfattende agonister av tyroidreseptoren
AR080875A1 (es) Inhibidores de la actividad de la proteina tirosina quinasa
HRP20110624T1 (hr) Supstituirani piperazinilpirazini kao antagonisti receptora 5-ht7
TW200531694A (en) Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
MY143578A (en) Piperazinediones as oxytocin receptor antagonists
HRP20110436T1 (hr) Supstituirani karboksamidi kao antagonisti metabotropnih receptora iz skupine i
JP2011500575A5 (OSRAM)